Suzhou Basecare Medical 2170

[winston]

vested

1H Results:-

Revenue: -14%
Losses: RMB 34m

https://www1.hkexnews.hk/listedco/listc ... 700243.pdf

[winston]

vested

BASECARE-B Proposes A Share Offering on SSE STAR Market

BASECARE-B (02170.HK) announced that the board had resolved on the proposed initial public offering of ordinary shares of the company to be traded in RMB on the Shanghai Stock Exchange STAR Market in order to optimize the company’s capital structure, enhance self-development capabilities and achieve strategic development goals.

BASECARE-B said the company will commence relevant preparatory work but has not formulated the offering plan or determined the structure of the Proposed A Share Offering, and has not applied to any relevant regulatory authorities in the People’s Republic of China or anywhere else for approval of the Proposed A Share Offering, and the Proposed A Share Offering will be subject to, among others, the formal approvals of the Board and the Shareholders and the approval of the China Securities Regulatory Commission and other relevant regulatory authorities.

Source: AAStocks Financial News

http://www.aastocks.com/en/stocks/news/ ... t-news/HK6

[winston]

vested

2022 Annual Report

http://iis.aastocks.com/20230425/10703845-0.PDF

[winston]

vested

AI》BASECARE-B(02170.HK) Displays Technical Pattern of Golden Cross

2023/06/21

BASECARE-B(02170.HK) 's SMA 10 crosses above SMA 20, which is a golden cross, a bullish technical signal.

Recent Performance
In 3 days: -6.162%
In 5 days: +1.208%
In 10 days: -2.899%

Recent transaction volume statistics:
Volume of last trading day: 90.50K shares
Average volume over the past 5 days: 100.20K shares

Technical analysis explanation:
Golden cross is a bullish signal, which the short term SMA crosses above long term SMA, such as SMA 50 crosses above SMA 250.

Source: AAStocks Financial News

http://www.aastocks.com/en/stocks/analy ... I17037/all

[winston]

vested

July 18, 2023

PROFIT ALERT

The total revenue of the Group for the six months ended June 30, 2023 is expected to be within the range of RMB79.4 million to RMB87.8 million, representing an increase in the range of 15.7% to 28.0% from RMB68.6 million for the six months ended June 30, 2022.

The increase in revenue of the Group is mainly attributable to the sales of PGT-A kits and cryopreservation system.

The gross profit of the Group for the six months ended June 30, 2023 is expected to be
within the range of RMB30.2 million to RMB36.4 million, representing an increase
in the range of no higher than 20.5% from RMB30.2 million for the six months ended
June 30, 2022.

The increase in gross profit is mainly due to increased revenue.

The Group’s overall gross profit margin for the six months ended June 30, 2023 is expected
to be within the range of 39.0% to 41.5%, which remains stable compared to the same
corresponding period of 2022.

https://www1.hkexnews.hk/listedco/listc ... 800003.pdf

[winston]

vested

August 30, 2023

1H 2023:-

Revenue: +25% ( RMB 85m)
Losses: RMB 63m

https://www1.hkexnews.hk/listedco/listc ... 002383.pdf

[winston]

vested

1H 2025 Results:-

Revenue: -19%; RMB 101m
Loss: RMB121m
Raised HK$1.8b (RMB 1.6b) from Global offering in Feb 2021

https://www1.hkexnews.hk/listedco/listc ... 902934.pdf